e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Assessing the relevance of obstructive airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
M. R. Miller, O. F. Pedersen, P. Lange, J. Vestbo (Birmingham, Manchester, United Kingdom; Aarhus, Copenhagen, Denmark)
Source:
Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Session:
Assessing the relevance of obstructive airway diseases
Session type:
Oral Presentation
Number:
3070
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. R. Miller, O. F. Pedersen, P. Lange, J. Vestbo (Birmingham, Manchester, United Kingdom; Aarhus, Copenhagen, Denmark). Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient. Eur Respir J 2005; 26: Suppl. 49, 3070
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Verification of flow rate stability in high-flow nasal cannula devices
DLCO biological controls in clinical practice.
Related content which might interest you:
Lung function measurement in respiratory diseases: mechanisms
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006
Early life origins of adult lung function
Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function
Year: 2006
Why should we perform lung function tests?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
FEF
25-75%
should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up
Source: Eur Respir J 2016; 47: 742-750
Year: 2016
Sources of variation in forced expiratory volume in one second and forced vital capacity
Source: Eur Respir J 2006; 27: 767-773
Year: 2006
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Prediction of respiratory disease mortality in a population sample is improved by expressing lung function impairment as FEV
1
quotient
Source: Eur Respir J 2005; 26: Suppl. 49, 217s
Year: 2005
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace
Source: Eur Respir J 2006; 27: 374-377
Year: 2006
Application and interpretation in RCT's
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Nutritional status from birth to adulthood and lung function in Chilean young adults
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity
Source: Eur Respir J 2008; 31: 391-395
Year: 2008
Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
Can the prediction point for FEV1 / FVC be determined in patients with insufficient expiratory maneuver to determine airflow obstruction?
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020
Comparison between peak expiratory flow rate (PEFR) and FEV1 in the monitoring of children suspected to asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002
Exercise test results and forced expiratory flow rates at low lung volumes
Source: Eur Respir J 2002; 20: Suppl. 38, 286s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept